Literature DB >> 31453

Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans.

D J Greenblatt, R I Shader, K Franke, D S MacLaughlin, J S Harmatz, M D Allen, A Werner, E Woo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 31453     DOI： 10.1002/jps.2600680119

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  46 in total

1.  Potential prediction of formulation performance in paediatric patients using biopharmaceutical tools and simulation of clinically relevant administration scenarios of nifedipine and lorazepam.

Authors:  Anna C Van der Vossen; Lidwien M Hanff; Arnold G Vulto; Nikoletta Fotaki
Journal:  Br J Clin Pharmacol       Date:  2019-06-18       Impact factor: 4.335

2.  Effect of orally administered misoprostol and cimetidine on the steady state pharmacokinetics of diazepam and nordiazepam in human volunteers.

Authors:  D R Lima; R M Santos; E Werneck; G N Andrade
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Jul-Sep       Impact factor: 2.441

3.  Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam.

Authors:  S K Gupta; E H Ellinwood; A M Nikaido; D G Heatherly
Journal:  J Pharmacokinet Biopharm       Date:  1990-04

Review 4.  Clinical pharmacokinetics of non-opiate abused drugs.

Authors:  U Busto; R Bendayan; E M Sellers
Journal:  Clin Pharmacokinet       Date:  1989-01       Impact factor: 6.447

5.  New treatments for agitation.

Authors:  Leslie Citrome
Journal:  Psychiatr Q       Date:  2004

6.  A study of conjugation and drug elimination in the human neonate.

Authors:  A J Cummings; A G Whitelaw
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

7.  Effect of age and sex on disposition of desmethyldiazepam formed from its precursor clorazepate.

Authors:  R I Shader; D J Greenblatt; D A Ciraulo; M Divoll; J S Harmatz; A Georgotas
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 8.  Clinical pharmacokinetics of oxazepam and lorazepam.

Authors:  D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  1981 Mar-Apr       Impact factor: 6.447

9.  Comparative pharmacokinetics of alprazolam and lorazepam in humans and in African Green Monkeys.

Authors:  H Friedman; D E Redmond; D J Greenblatt
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

10.  Disposition of oxazepam in relation to age, sex, and cigarette smoking.

Authors:  H R Ochs; D J Greenblatt; H Otten
Journal:  Klin Wochenschr       Date:  1981-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.